Opal Opal – China Drug Master File

Provisions for Administration of Drug-related Associated Review & Approval for APIs, Excipients. and Packaging Materials (2020 Draft for Comments)

Announcement on Issues Concerning the Further Improvement of Drug-related Associated Review & Approval and Supervision (2019 No.56)

Announcement for Adjusting Evaluation and Approval for APls, Excipients and Packaging Materials (2017 No.146)